期刊名
Biomolecules

BIOMOLECULES

ISSN / eISSN
2218-273X / 2218-273X
目标和范围
Biomolecules (ISSN 2218-273X) is an international, peer-reviewed open access journal focusing on biogenic substances and their biological functions, structures, interactions with other molecules, and their microenvironment as well as biological systems. Biomolecules publishes reviews, regular research papers and short communications.  Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
研究方向

生化与分子生物学

CiteScore
8.30 查看趋势图
CiteScore 学科排名
类别 分区 排名
Biochemistry, Genetics and Molecular Biology - Biochemistry Q1 #94/428
Biochemistry, Genetics and Molecular Biology - Molecular Biology Q2 #114/380
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE Q1
出版国家或地区
Switzerland
出版商
MDPI (Basel, Switzerland)
出版年份
2011
年文章数
1843
Open Access
YES
通讯方式
ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
Research on biomarkers, a special issue was submitted. The efficiency was very high, with a first review taking 20 days and involving 4 reviewers. One of the reviewers raised many statistical questions, which required additional analysis. The second review took 4 days, with 3 reviewers providing additional comments mainly on language and formatting issues. After revisions were made, the paper was accepted within 2 days and underwent a 2-day proofreading process before being published online on the same day. The status changes in the system were as follows:

Pending review (Aug 26)
Under review (Aug 30)
Pending major revision (Sep 19)
Resubmit 1st round (Oct 4)
Pending minor revision (Oct 8)
Resubmit 2nd round (Oct 10)
Pending editor decision (Oct 10)
Accept (Oct 12)
Proof resubmit (Oct 14)
2022-10-14
The reviewer's comments were sharp, but the overall opinion was leaning towards positive. However, in the end, the paper was rejected by the editor but encouraged for resubmission. After making revisions and conducting additional experiments based on the reviewer's comments, the paper went through two more rounds of review, which were much stricter than my stereotypical impression of MDPI. After resubmission, it took less than a month for the paper to be accepted, so the process was still quite fast.
2022-02-09

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now